Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-003278
Filing Date
2025-04-08
Accepted
2025-04-08 17:31:48
Documents
83

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 5884992
2 ex5-1.htm EX-5.1 28767
3 ex23-1.htm EX-23.1 4005
4 logo_001.jpg GRAPHIC 68479
5 ex5-1_001.jpg GRAPHIC 4262
  Complete submission text file 0001641172-25-003278.txt   19574050

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ppcb-20240630.xsd EX-101.SCH 77761
7 XBRL CALCULATION FILE ppcb-20240630_cal.xml EX-101.CAL 82562
8 XBRL DEFINITION FILE ppcb-20240630_def.xml EX-101.DEF 418887
9 XBRL LABEL FILE ppcb-20240630_lab.xml EX-101.LAB 618768
10 XBRL PRESENTATION FILE ppcb-20240630_pre.xml EX-101.PRE 538046
86 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 3216562
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-282886 | Film No.: 25823083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)